ArticleBMJ open2021

New chemotherapy regimens and biomarkers for Chagas disease: the rationale and design of the TESEO study, an open-label, randomised, prospective, phase-2 clinical trial in the Plurinational State of Bolivia.

Cristina Alonso-Vega et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.